What is the dose of Macrobid (Nitrofurantoin) for a one-month-old infant?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Nitrofurantoin (Macrobid) is not recommended for infants under 4 months of age due to the risk of hemolytic anemia, as stated in a recent study published in 2024 1. When considering the treatment of urinary tract infections (UTIs) in infants, it is crucial to prioritize their safety and efficacy.

  • The use of nitrofurantoin in infants under 4 months is best avoided due to the risk of hemolytic anemia 1.
  • For a one-month-old infant, alternative antibiotics should be considered, taking into account the specific clinical situation and local resistance patterns.
  • A pediatrician should evaluate the infant and prescribe an age-appropriate antibiotic, such as amoxicillin, ampicillin, or gentamicin, based on culture results and sensitivity testing.
  • The choice of antibiotic should be guided by the most recent and highest-quality evidence available, prioritizing the infant's morbidity, mortality, and quality of life.
  • In the context of continuous antibiotic prophylaxis (CAP) for vesicoureteral reflux (VUR), the literature recommends prescribing daily antibiotics at a quarter to half of the regular therapeutic dose, with trimethoprim-sulfamethoxazole, amoxicillin, and nitrofurantoin being the most commonly used antibiotics 1.
  • However, for infants under 4 months, nitrofurantoin is not recommended due to the risk of hemolytic anemia, and alternative antibiotics should be used instead 1.

From the Research

Dosage of Macrobid for a One-Month-Old Infant

  • The provided studies do not directly address the dosage of Macrobid (Nitrofurantoin) for a one-month-old infant.
  • Studies 2, 3, and 4 discuss the use of Nitrofurantoin in adults, with no mention of pediatric dosing.
  • Study 5 reports a case of nitrofurantoin-induced haemolysis in an adult patient, but does not provide information on pediatric dosing.
  • Study 6 is unrelated to the topic of Macrobid dosing, as it discusses the effects of aerobic exercise during pregnancy on infant neuromotor skills.
  • There is no direct evidence in the provided studies to support a specific dosage of Macrobid for a one-month-old infant, and dosing information for this age group is not mentioned in the studies 2, 3, 4, 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Nitrofurantoin: what is the evidence for current UK guidance?

The Journal of antimicrobial chemotherapy, 2023

Research

Nitrofurantoin's efficacy and safety as prophylaxis for urinary tract infections: a systematic review of the literature and meta-analysis of controlled trials.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2017

Research

Nitrofurantoin safety and effectiveness in treating acute uncomplicated cystitis (AUC) in hospitalized adults with renal insufficiency: antibiotic stewardship implications.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2017

Research

Effects of Aerobic Exercise during Pregnancy on 1-Month Infant Neuromotor Skills.

Medicine and science in sports and exercise, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.